Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma

被引:55
|
作者
Giovanella, Luca [1 ,2 ,3 ]
Ceriani, Luca [1 ,2 ]
Suriano, Sergio [3 ]
Ghelfo, Antonella [4 ]
Maffioli, Marco [5 ]
机构
[1] Oncol Inst So Switzerland, Dept Nucl Med, CH-6500 Bellinzona, Switzerland
[2] Oncol Inst So Switzerland, Thyroid Unit, CH-6500 Bellinzona, Switzerland
[3] Ente Osped Cantonale, Dept Clin Chem & Lab Med, CH-6500 Bellinzona, Switzerland
[4] Univ Hosp Fdn Macchi, Dept Nucl Med, I-21100 Varese, Italy
[5] Univ Hosp Fdn Macchi, Dept ENT Head & Neck Surg, I-21100 Varese, Italy
关键词
D O I
10.1111/j.1365-2265.2008.03244.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim Thyroidectomy followed by administration of large activities of 131-iodine (I-131) is the treatment of choice for differentiated thyroid carcinoma (DTC). The serum thyroglobulin (Tg) measurement during hypothyroidism (offT4-Tg), just before radioiodine thyroid ablation, has proved to be effective for predicting persistent/recurrent disease. However, the Tg measurement cannot be used as a corresponding value for pre-ablative offT4-Tg when recombinant human TSH (rhTSH) is used as stimulus before treatment. The present study was undertaken to evaluate if post-thyroidectomy Tg values, measured before rhTSH-stimulated radioiodine ablation is of prognostic value in patients affected by DTC. Methods We enrolled 126 patients with DTC submitted to total thyroidectomy. T4 treatment was started just after surgery to suppress TSH levels and Tg levels (onT4-Tg) were measured just before rhTSH-aided thyroid ablation by I-131 (3700 MBq). Neck radioiodine uptake (RAIU) was measured just before ablation and a post-treatment whole body scan (PT-WBS) was performed. Results A significant relationship was found between thyroid remnants' RAIU and onT4-Tg levels (P < 0.001). The 1.10 ng/ml onT4-Tg threshold selected by ROC curve analysis identifies patients with positive PT-WBS with 83.3% sensitivity, 65.7% specificity, 44.5% positive predictive value (PPV) and 93.6% negative predictive value (NPV). The 0.65 ng/ml cut-off level recognizes metastatic patients with 82.9% sensitivity, 55.2% specificity, 43.3% PPV and 97.8% NPV when compared with 12 months restaging results. Among 63 patients with initially undetectable onT4-Tg (i.e. <= 0.2 ng/ml) none had positive PT-WBS nor DTC relapse at 12-month restaging (NPV 100%). Conclusions Based on our data we conclude that pre-ablative onT4-Tg is a prognostic marker and should be used instead of pre-ablative TSH-stimulated Tg measurement when rhTSH-aided radioiodine ablation is done.
引用
收藏
页码:659 / 663
页数:5
相关论文
共 50 条
  • [1] Is the thyroglobulin measurement under thyroxine of prognostic value before rhTSH-aided radioiodine ablation in differentiated thyroid carcinoma?
    Giovanella, L.
    Ceriani, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S230 - S230
  • [2] rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
    Luster, M
    Lippi, F
    Jarzab, B
    Perros, P
    Lassmann, M
    Reiners, C
    Pacini, F
    [J]. ENDOCRINE-RELATED CANCER, 2005, 12 (01) : 49 - 64
  • [3] Ruling Out 131I Ablation in Low-Risk Differentiated Thyroid Carcinoma Basing on Thyroglobulin Measurement
    Giovanella, Luca
    Verburg, Frederik A.
    [J]. THYROID, 2011, 21 (07) : 809 - 810
  • [4] Thyroglobulin (Tg) response to multiple rhTSH-aided radioiodine treatments (rhTSH-RITs) in patients with advanced differentiated thyroid carcinoma (DTC)
    Handkiewicz-Junak, Daria
    Marlowe, Robert
    Roskosz, Jozef
    Hasse-Lazar, Kornelia
    Szpak-Ulczok, Sylwia
    Jarzab, Barbara
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [5] 131I treatment for brain metastases from differentiated thyroid carcinoma
    YU Yong-Li
    [J]. Nuclear Science and Techniques, 2004, (04) : 223 - 226
  • [6] Ruling Out 131I Ablation in Low-Risk Differentiated Thyroid Carcinoma Basing on Thyroglobulin Measurement Response
    Rosario, Pedro Weslley
    [J]. THYROID, 2011, 21 (07) : 811 - 812
  • [7] Empiric 131I Treatment of High Thyroglobulin Levels in Differentiated Thyroid Carcinoma After Remmant Ablation
    Kalender, E.
    Elboga, U.
    Celen, Y.
    Demir, H.
    Sahin, E.
    Yilmaz, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S503 - S503
  • [8] EMPIRIC 131I TREATMENT OF HIGH THYROGLOBULIN LEVELS IN DIFFERENTIATED THYROID CARCINOMA AFTER REMNANT ABLATION
    Kalender, Ebuzer
    Elboga, Umut
    Celen, Y. Zeke
    Demir, H. Deniz
    Sahin, Ertan
    Karacavus, Seyhan
    [J]. ACTA MEDICA MEDITERRANEA, 2014, 30 (02): : 503 - 507
  • [9] Impact of TNM status on rhTSH-aided I-131 thyroid remnant ablation (rhTSH-A) success in patients (pats) with differentiated thyroid cancer (DTC): Preliminary data from an international, multicenter retrospective study
    Ferreira, Teresa
    Antonio Vallejo, Juan
    Brezhnev, Mikhailo
    Freudenberg, Lutz
    Cherenko, Sergey
    Handkiewicz-Junak, Daria
    Duntas, Leonidas
    Verburg, Frederik
    Marlowe, Robert
    Petrich, Thorsten
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [10] Dosimetry of 131I in remnant ablation and metastasis of differentiated thyroid cancer treated with high radioactivities and rhTSH
    Ramirez-Franco, Jorge
    Torres-Garcia, Eugenio
    Flores-Reyes, Mario
    Torres-Garcia, Gustavo
    Perez-Soto, Elvia
    [J]. RADIATION EFFECTS AND DEFECTS IN SOLIDS, 2024, 179 (9-10): : 1284 - 1294